Parents of Preemies with NEC: You May Be Owed Compensation. Contact Us Today For a Free Case Evaluation.
Pfizer has recently issued a global recall of OXBRYTA®, a medication to treat the symptoms of sickle cell disease. Recent studies have shown that OXBRYTA—rather than helping those with sickle cell disease—may actually significantly increase the risk of dangerous complications, including vaso-occlusive crises (VOCs) and even death. Keller Postman LLC is representing clients in actions against Pfizer for these harms.
If you or a loved one were prescribed OXBRYTA for sickle cell disease and experienced worsening symptoms or complications, you may be entitled to compensation. Our attorneys are dedicated to holding Pfizer accountable, and we are here to fight for the recovery you deserve.
OXBRYTA (voxelotor) was marketed as a groundbreaking treatment for sickle cell disease (SCD), designed to increase hemoglobin’s affinity for oxygen and reduce the sickling of red blood cells. Approved by the FDA in 2019, OXBRYTA was hailed as a major advancement for people living with SCD. Studies have since revealed that the risks of taking OXBRYTA outweigh its benefits. Patients who used the drug faced a higher likelihood of developing severe complications such as VOCs, which can lead to life-threatening outcomes.
Sickle cell disease is an extremely difficult condition to live with, and many patients trusted OXBRYTA to manage their condition. Pfizer’s failure to disclose the full scope of the drug’s risks has led to preventable suffering for countless individuals. Keller Postman is committed to helping these patients seek justice and compensation.
Vaso-Occlusive Crises (VOCs): OXBRYTA has been linked to an increased risk of VOCs, a painful and dangerous complication of sickle cell disease. VOCs occur when sickled red blood cells block blood flow to tissues, causing severe pain and leading to potential organ damage. Patients who took OXBRYTA experienced more frequent VOCs compared to those who did not use the drug, putting them at greater risk of long-term health issues, including kidney failure and stroke.
Fatal Complications: Tragically, some patients who took OXBRYTA suffered fatal complications. Studies revealed a higher rate of deaths among those on OXBRYTA compared to a placebo, raising serious questions about Pfizer’s safety protocols and commitment to patient welfare.
Keller Postman LLC is at the forefront of litigation against Pfizer, representing individuals who have suffered from the severe side effects of OXBRYTA. We believe that Pfizer failed to adequately test the drug and disclose the serious risks it posed to sickle cell patients. Our attorneys are working to hold Pfizer accountable for the harm caused by OXBRYTA and secure the compensation our clients deserve.
Call us or fill out a no-cost claim review today to learn how we can assist you in seeking justice. Don’t wait—time is of the essence in pursuing your claim.
Meet the attorneys leading the Oxbryta Litigation.
Our world-class team of attorneys, case managers, and tech engineers work together to serve the hundreds of thousands of clients who have chosen us to represent them—and we put all of our power behind each of our clients and each of their cases. Our attorneys have attended the top law schools in the country and have honed their skills in esteemed clerkships, AmLaw100 firms, national trial boutiques, corporate in-house legal departments, and prestigious government posts.
We stop at nothing until we achieve justice for our clients. Our team has the determination, skills, and resources to go head-to-head with the largest, most well-resourced corporations in the world. We prize innovation both in the practice of law and in how we do business, combining high-end legal expertise with best practices in operations and technology to deliver superlative representation for plaintiffs.
We make the litigation process easy and approachable for our clients—because justice should never be intimidating. When clients work with us, we help them learn about their rights, easily file their claim, and keep them informed the whole way through. Our effortless process has led to sizeable settlements for hundreds of thousands of clients.
We make things easy for you. We’ll gather the evidence you need with the lowest burden on you. And with a large client base, we will have efficiencies to reduce costs and the leverage to pursue the best outcomes we can for our clients.
Pfizer voluntarily recalled OXBRYTA after studies indicated an increased risk of complications, including vaso-occlusive crises (VOCs) and fatalities, in patients with sickle cell disease.
You may be eligible to file a claim if you or a family member were prescribed OXBRYTA and experienced complications such as worsening symptoms, increased VOCs, or other health issues. Families of individuals who have passed away due to complications related to OXBRYTA may also be eligible.
Compensation may cover medical expenses, costs related to the failure of OXBRYTA to alleviate your symptoms, or damages for health complications caused by the drug. Each case is unique, and our legal team will assess your situation to determine the potential compensation you may be entitled to. Our team of attorneys would not be surprised if successful claimants received hundreds of thousands of dollars.